TargTex is determined to find novel correlations between small molecules and targets that are overexpressed in oncological indication. Our lead product is being developed as an adjunct to surgery taking advantage its selectivity towards an unexplored target in Glioblastoma Multiforme.

TargTex is developing a concerted approach, aligning scientists, physicians and patients to advance an innovative therapy to treat a daunting disease, giving a chance to Glioblastoma Multiforme patients to live instead of surviving.